Author: Philip M. Parker
Manufacturer: ICON Group International, Inc.
This study covers the latent demand outlook for sulfonamide pharmaceuticals excluding sulfa-antibiotic
combinations across the states and cities of the United States. Latent demand (in millions of U.S.
dollars), or potential industry earnings (P.I.E.) estimates are given across some 9, 000 cities in the United States. For each city in question, the percent share the city is of it's state and of the United States is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-